Skip to content

A Study on the Application Value of Contrast-Enhanced Ultrasound with Injectable Perfluoropropane Human Serum Albumin Microspheres in Evaluating High-Intensity Focused Ultrasound Treatment for Uterine Fibroids

A Study on the Application Value of Contrast-Enhanced Ultrasound with Injectable Perfluoropropane Human Serum Albumin Microspheres in Evaluating High-Intensity Focused Ultrasound Treatment for Uterine Fibroids

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600120833
Enrollment
Unknown
Registered
2026-03-20
Start date
2026-03-20
Completion date
Unknown
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterine Fibroids

Interventions

Uterine fibroid observation group:None

Sponsors

Suining Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Has uterine fibroids with a maximum diameter of >= 3 cm; 2. The uterine fibroids are located within the ultrasound path and the focal area can accommodate them; 3. The acoustic channel is safe; 4. There are indications for FUAS treatment and the plan is to undergo FUAS treatment; 5. MRI examinations will be conducted before and after the planned FUAS treatment; 6. Voluntarily participates in this study, understands and signs the written informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with pregnancy or lactation; 2. Highly suspected uterine sarcoma or other gynecological reproductive system tumors; 3. Complicated with organ failure or moderate to severe anemia; 4. Complicated with severe cardiovascular diseases and other contraindications for CEUS and MRI examinations; 5. History of collagen connective tissue diseases or abdominal radiotherapy; 6. Situations judged by the investigator as not suitable for participating in this study.

Design outcomes

Primary

MeasureTime frame
Non-perfused volume(NPV);

Countries

China

Contacts

Public ContactHuang Guohua

Suining Central Hospital

382595395@qq.com+86 825 2292378

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 3, 2026